There is evidence supporting the hypothesis that inflammation participates in providing
conditions that lead to cancer. An unresolved inflammation due to any failure in the precise …

Abstract The Inflammation and Cancer Think Tank Meeting was organized by the National
Cancer Institute with the purpose of identifying research advances, gaps, and opportunities …

Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-
40% of colorectal cancer patients. The hallmarks of systemic inflammation include an …

Inflammation is emerging as one of the hallmarks of cancer, yet its role in most tumors
remains unclear. Whereas a minority of solid tumors are associated with overt inflammation …

State of the Art: Mounting evidence indicates a link between inflammation and cancer.
However, the molecular mechanism (s) remains unclear. Indeed, although preclinical and …

Tumor-promoting inflammation is one of the hallmarks of cancer. It has been shown that
cancer development is strongly influenced by both chronic and acute inflammation process …

Gastrointestinal cancers collectively rank as the most lethal cancers worldwide, and are
strongly linked with chronic inflammation. Despite advances over the last decade into our …

Pathogens or genotoxic agents continuously affect the human body. Acute inflammatory
reaction induced by a non-sterile or sterile environment is triggered for the efficient …

Inflammation, especially chronic inflammation, plays a pivotal role in tumorigenesis and
metastasis through various mechanisms and is now recognized as a hallmark of cancer and …

An inflammatory component is present in the microenvironment of most neoplastic tissues,
including those not causally related to an obvious inflammatory process. Epidemiological …